Clinical trial
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone…
NCT00460512 · Janssen-Cilag International NV, Industry · Completed
Key facts
| NCT number | NCT00460512 |
|---|---|
| Title | An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia |
| Official title | An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia |
| Acronym | PERFlexS |
| Lead sponsor | Janssen-Cilag International NV, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Paliperidone ER |
| Enrollment | 1,814 |
| Start date | Apr 25, 2007 |
| Primary completion | Jan 22, 2009 |
| Completion | Mar 4, 2020 |
| First posted | Apr 16, 2007 |
| Last update posted | Apr 27, 2025 |
| Countries | Belgium, Bulgaria, Croatia, Denmark, Finland, France, Germany, Greece, Hungary, Israel, Latvia, Lithuania and 10 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: